The next FDA commissioner — most likely Robert Califf, who is now awaiting a confirmation vote by the Senate — will face a tough 2022 on multiple fronts, beyond just dealing with the ongoing pandemic and drug supply-chain shortages.
Source: Drug Industry Daily